tuftsin has been researched along with Sepsis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, YF; Dong, N; Gao, YL; Han, S; Yao, YM; Zhang, QH; Zhu, XM | 1 |
Chai, YF; Gao, YL; Liu, YC; Lu, B; Shou, ST; Wang, LJ; Yao, Y; Yu, MM | 1 |
Dabrowska-Szponar, M; Dzierzbicka, K; Myśliwski, A; Szaryńska, M; Trzonkowski, P; Wardowska, A; Wiśniewska, K | 1 |
Mücke, D | 1 |
Quie, PG | 1 |
Spirer, Z | 1 |
Lishke, AA; Surkova, TP | 1 |
Trigg, ME | 1 |
2 review(s) available for tuftsin and Sepsis
Article | Year |
---|---|
[Tuftsin].
Topics: Animals; Bacteria; Humans; Leukocytes; Macrophages; Mice; Monocytes; Neuraminidase; Phagocytosis; Receptors, IgG; Receptors, Immunologic; Retroviridae; RNA-Directed DNA Polymerase; Sepsis; Splenectomy; Tuftsin; Virus Replication | 1984 |
Immune function of the spleen.
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Antigens; Bacterial Infections; Child, Preschool; Hodgkin Disease; Humans; Immunity, Cellular; Infant; Infant, Newborn; Kidney Transplantation; Malaria; Models, Biological; Premedication; Purpura, Thrombocytopenic; Risk; Sepsis; Spleen; Splenectomy; Transplantation Immunology; Transplantation, Homologous; Tuftsin | 1979 |
6 other study(ies) available for tuftsin and Sepsis
Article | Year |
---|---|
Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice.
Topics: Animals; Antigens, Surface; Apoptosis; CTLA-4 Antigen; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression; Immunity, Cellular; Immunologic Factors; Immunomodulation; Immunophenotyping; Interleukin-2; Lymphocyte Activation; Mice; Phenotype; Sepsis; T-Lymphocyte Subsets; Transforming Growth Factor beta; Tuftsin | 2015 |
Tuftsin prevents the negative immunoregulation of neuropilin-1highCD4+CD25+Regulatory T cells and improves survival rate in septic mice.
Topics: Animals; Cells, Cultured; CTLA-4 Antigen; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Immunologic Factors; Interleukin-2 Receptor alpha Subunit; Male; Mice, Inbred BALB C; Neuropilin-1; Sepsis; Signal Transduction; T-Lymphocytes, Regulatory; Time Factors; Transforming Growth Factor beta; Tuftsin | 2016 |
Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Colony Count, Microbial; Cytokines; Escherichia coli Infections; Gene Expression Profiling; Immunologic Factors; Inflammation; Liver; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Polymerase Chain Reaction; Sepsis; Tuftsin | 2009 |
Humoral factors in host defense against microbial invaders.
Topics: Antibody Formation; Complement System Proteins; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Sepsis; Tuftsin | 1982 |
The role of the spleen in immunity and infection.
Topics: Adult; Anemia, Sickle Cell; Animals; Child; Child, Preschool; Erythroblastosis, Fetal; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Mice; Middle Aged; Mononuclear Phagocyte System; Pneumococcal Infections; Pregnancy; Rats; Sepsis; Spleen; Splenectomy; Tuftsin | 1980 |
[Clinical immunological characteristics of infants to 2 years of age with suppurative, septic diseases of staphylococcal etiology].
Topics: Antitoxins; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Infant; Sepsis; Staphylococcal Infections; Tuftsin | 1980 |